Cargando…

The liver steatosis severity and lipid characteristics in primary biliary cholangitis

BACKGROUND: Patients with primary biliary cholangitis (PBC) often have comorbid dyslipidemia, and determining the degree of hepatic steatosis can help predict the risk of cardiovascular events in PBC patients. The aim of our study was to analyze the characteristics of lipid distribution and the degr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuan, Hu, Xing, Chang, Jing, Chen, Jie, Han, Xue, Zhang, Tieying, Shen, Jianjun, Shang, Ning, Han, Jing, Wang, Hui, Kang, Weiwei, Meng, Fankun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532358/
https://www.ncbi.nlm.nih.gov/pubmed/34686147
http://dx.doi.org/10.1186/s12876-021-01974-4
_version_ 1784587051263328256
author Zhang, Yuan
Hu, Xing
Chang, Jing
Chen, Jie
Han, Xue
Zhang, Tieying
Shen, Jianjun
Shang, Ning
Han, Jing
Wang, Hui
Kang, Weiwei
Meng, Fankun
author_facet Zhang, Yuan
Hu, Xing
Chang, Jing
Chen, Jie
Han, Xue
Zhang, Tieying
Shen, Jianjun
Shang, Ning
Han, Jing
Wang, Hui
Kang, Weiwei
Meng, Fankun
author_sort Zhang, Yuan
collection PubMed
description BACKGROUND: Patients with primary biliary cholangitis (PBC) often have comorbid dyslipidemia, and determining the degree of hepatic steatosis can help predict the risk of cardiovascular events in PBC patients. The aim of our study was to analyze the characteristics of lipid distribution and the degree of hepatic steatosis in PBC. METHODS: We retrospectively analyzed 479 cases of PBC, chronic hepatitis B (CHB), chronic hepatitis C (CHC), non-alcoholic fatty liver disease (NAFLD), and healthy subjects (Normal) diagnosed by liver biopsy or definitive clinical diagnosis. Controlled attenuation parameter (CAP) values were applied to assess the degree of steatosis of the liver, and lipid levels were also compared in the five cohorts. RESULTS: We found that among the five groups of subjects, the PBC group had the lowest CAP values (P < 0.001), and the high-density lipoprotein cholesterol (HDL-C) level in the PBC group was higher than normal, CHC and CHB group (P = 0.004, P = 0.033, P < 0.001, respectively).In the multivariate linear analysis, only BMI (β = 1.280, P = 0.028), ALP (β = − 0.064, P = 0.012), TBA (β = − 0.126, P = 0.020), TG (β = 12.520, P = 0.000), HDL-C (β = − 11.338, P = 0.001) and LDL-C (β = 7.012, P = 0.002) were independent predictors of CAP. CONCLUSIONS: Among PBC, CHB, CHC, NAFLD and healthy subjects, PBC had the lowest degree of hepatic steatosis and higher HDL-C levels, all of which were found to be protective factors against atherosclerosis and cardiovascular risk and would provide a valuable reference for the risk of developing cardiovascular events in PBC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-01974-4.
format Online
Article
Text
id pubmed-8532358
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85323582021-10-25 The liver steatosis severity and lipid characteristics in primary biliary cholangitis Zhang, Yuan Hu, Xing Chang, Jing Chen, Jie Han, Xue Zhang, Tieying Shen, Jianjun Shang, Ning Han, Jing Wang, Hui Kang, Weiwei Meng, Fankun BMC Gastroenterol Research BACKGROUND: Patients with primary biliary cholangitis (PBC) often have comorbid dyslipidemia, and determining the degree of hepatic steatosis can help predict the risk of cardiovascular events in PBC patients. The aim of our study was to analyze the characteristics of lipid distribution and the degree of hepatic steatosis in PBC. METHODS: We retrospectively analyzed 479 cases of PBC, chronic hepatitis B (CHB), chronic hepatitis C (CHC), non-alcoholic fatty liver disease (NAFLD), and healthy subjects (Normal) diagnosed by liver biopsy or definitive clinical diagnosis. Controlled attenuation parameter (CAP) values were applied to assess the degree of steatosis of the liver, and lipid levels were also compared in the five cohorts. RESULTS: We found that among the five groups of subjects, the PBC group had the lowest CAP values (P < 0.001), and the high-density lipoprotein cholesterol (HDL-C) level in the PBC group was higher than normal, CHC and CHB group (P = 0.004, P = 0.033, P < 0.001, respectively).In the multivariate linear analysis, only BMI (β = 1.280, P = 0.028), ALP (β = − 0.064, P = 0.012), TBA (β = − 0.126, P = 0.020), TG (β = 12.520, P = 0.000), HDL-C (β = − 11.338, P = 0.001) and LDL-C (β = 7.012, P = 0.002) were independent predictors of CAP. CONCLUSIONS: Among PBC, CHB, CHC, NAFLD and healthy subjects, PBC had the lowest degree of hepatic steatosis and higher HDL-C levels, all of which were found to be protective factors against atherosclerosis and cardiovascular risk and would provide a valuable reference for the risk of developing cardiovascular events in PBC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-01974-4. BioMed Central 2021-10-22 /pmc/articles/PMC8532358/ /pubmed/34686147 http://dx.doi.org/10.1186/s12876-021-01974-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Yuan
Hu, Xing
Chang, Jing
Chen, Jie
Han, Xue
Zhang, Tieying
Shen, Jianjun
Shang, Ning
Han, Jing
Wang, Hui
Kang, Weiwei
Meng, Fankun
The liver steatosis severity and lipid characteristics in primary biliary cholangitis
title The liver steatosis severity and lipid characteristics in primary biliary cholangitis
title_full The liver steatosis severity and lipid characteristics in primary biliary cholangitis
title_fullStr The liver steatosis severity and lipid characteristics in primary biliary cholangitis
title_full_unstemmed The liver steatosis severity and lipid characteristics in primary biliary cholangitis
title_short The liver steatosis severity and lipid characteristics in primary biliary cholangitis
title_sort liver steatosis severity and lipid characteristics in primary biliary cholangitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532358/
https://www.ncbi.nlm.nih.gov/pubmed/34686147
http://dx.doi.org/10.1186/s12876-021-01974-4
work_keys_str_mv AT zhangyuan theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT huxing theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT changjing theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT chenjie theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT hanxue theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT zhangtieying theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT shenjianjun theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT shangning theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT hanjing theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT wanghui theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT kangweiwei theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT mengfankun theliversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT zhangyuan liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT huxing liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT changjing liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT chenjie liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT hanxue liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT zhangtieying liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT shenjianjun liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT shangning liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT hanjing liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT wanghui liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT kangweiwei liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis
AT mengfankun liversteatosisseverityandlipidcharacteristicsinprimarybiliarycholangitis